Verilogue to Present on Patient-Physician Vaccine Discussions at 2009 International Conference on Communication in Healthcare
-(Business Wire)-September 29, 2009 - Verilogue:
| WHO: | David Franke, Verilogue Director of Linguistic Insights and Analytics | |
| WHAT: | Franke will deliver a presentation entitled “Patient Autonomy, Clinical Objectivity and the Ethics of Physician Persuasion in Vaccine Discussions.” | |
| Recently, patients and caregivers have become wary of vaccine safety and physicians’ motives in making recommendations to vaccinate. Franke’s presentation will offer insights into the communicative challenge and ethical dilemma for physicians when recommending vaccines to patients, referencing data from Verilogue’s study on physicians who recommended the Gardasil vaccine. The study demonstrates how physicians use a wide range of strategies to deliver information about Gardasil and addresses the broader question around how physicians balance their roles as objective treatment providers and subjective persuaders. | ||
| WHEN: | Monday, October 5, 2009, 1:30-3:00 p.m. ET | |
| WHERE: | International Conference on Communication in Healthcare to be held October 4-7, 2009 in Miami. This year’s conference will emphasize ethical issues in healthcare communication, patient safety as a communication issue and inter-cultural issues in communication. The conference is organized by the American Academy on Communication in Healthcare (AACH) in partnership with the European Association for Communication in Healthcare (EACH). |
About Verilogue
Verilogue (www.verilogue.com) is the first health care market research company to uncover, analyze and deliver nationwide insights derived from naturally-occurring dialogue between patients and physicians. With its patent-pending Point-of-Practice™ database and technology system, which digitally records real-time conversations between patients and physicians, Verilogue is able to capture critical information at the point of care, while maintaining patient and physician confidentiality. The insights gathered from these conversations, analyzed by Verilogue’s team of linguists, statisticians and marketing experts, enable pharmaceutical and health care companies to gain a deeper understanding of patient and physician perspectives, help shape conversations that affect health care decisions, identify the most effective methods and tools to reach patients and drive the development and improvement of new and existing treatments to ultimately improve patient care.
More than 25 pharmaceutical companies have partnered with Verilogue to gain actionable insights from its database containing 30,000+ unique physician-patient conversations and corresponding patient charts across 50+ therapeutic categories. Founded in 2006, Verilogue is a privately-held company headquartered in Horsham, PA.
 |
 |
 |
|
||
 |
|
 |
|
||
Search Our News Using Google Search
Can't find what you want? Try using Google:
